首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   426篇
  免费   47篇
耳鼻咽喉   1篇
儿科学   60篇
妇产科学   14篇
基础医学   105篇
口腔科学   9篇
临床医学   37篇
内科学   65篇
皮肤病学   7篇
神经病学   12篇
特种医学   63篇
外科学   22篇
综合类   27篇
预防医学   24篇
眼科学   1篇
药学   16篇
中国医学   1篇
肿瘤学   9篇
  2021年   9篇
  2020年   3篇
  2019年   3篇
  2018年   8篇
  2017年   6篇
  2016年   10篇
  2015年   19篇
  2014年   26篇
  2013年   18篇
  2012年   14篇
  2011年   13篇
  2010年   21篇
  2009年   11篇
  2008年   16篇
  2007年   7篇
  2006年   10篇
  2005年   15篇
  2004年   6篇
  2003年   5篇
  2002年   7篇
  2001年   5篇
  2000年   4篇
  1999年   4篇
  1998年   11篇
  1997年   15篇
  1996年   12篇
  1995年   17篇
  1994年   14篇
  1993年   11篇
  1992年   7篇
  1991年   9篇
  1990年   4篇
  1989年   17篇
  1988年   14篇
  1987年   11篇
  1986年   8篇
  1985年   7篇
  1984年   8篇
  1983年   5篇
  1982年   3篇
  1981年   5篇
  1980年   6篇
  1978年   4篇
  1977年   8篇
  1976年   5篇
  1973年   3篇
  1972年   3篇
  1971年   3篇
  1961年   2篇
  1923年   2篇
排序方式: 共有473条查询结果,搜索用时 15 毫秒
1.
2.
3.
Risk is a concept inherent in every medical procedure. It can be defined as the probability of an adverse event in a defined population over a specified period of time. In the frame of food allergy management, it might be related to a diagnostic procedure, a treatment, or the consumption of foods. The risk of an adverse event can also be augmented by individual factors. This rostrum article discusses various aspects faced by children with food allergies in the light of risk, and their practical implications. Identifying personal risks for severe reaction, such as unstable asthma, and correcting them whenever possible also contribute to a reduction of the risk inherent to food allergy. Among the facets discussed, oral food challenges (OFC) are the most common diagnostic procedures implying an inherent risk. The risk of OFCs can be minimized by correct indication and timing of the test, a safe setting, as well as by ensuring that the patient is otherwise well without potential stressor potentially increasing the risk of a more severe reaction. Oral immunotherapy (OIT) has been studied as a potential treatment for increasing the threshold dose for reaction, and thus reducing the risk of accidental reaction. Nevertheless, the procedure is not devoid of risk as the patients may and do often react during the course of the procedure. Ingestion of trace amounts in processed foods, mainly in community settings such as restaurants, schools, or day care, represents a potential risk of reactions, although for a minority of patients. Precautionary allergen labeling (PAL) is a widespread strategy to reduce the potential risk of reactions due to traces. However, PAL is currently inefficient due to inconsistent labeling, also not indicating a clear maximum amount possibly present in the manufactured food. Finally, cost-effectiveness needs to be considered in risk management, as many risk reduction procedures are clearly not cost-effective.  相似文献   
4.

Background

Peanut allergy has a rising prevalence in high-income countries, affecting 0.5%–1.4% of children. This study aimed to better understand peanut anaphylaxis in comparison to anaphylaxis to other food triggers in European children and adolescents.

Methods

Data was sourced from the European Anaphylaxis Registry via an online questionnaire, after in-depth review of food-induced anaphylaxis cases in a tertiary paediatric allergy centre.

Results

3514 cases of food anaphylaxis were reported between July 2007 - March 2018, 56% in patients younger than 18 years. Peanut anaphylaxis was recorded in 459 children and adolescents (85% of all peanut anaphylaxis cases). Previous reactions (42% vs. 38%; p = .001), asthma comorbidity (47% vs. 35%; p < .001), relevant cofactors (29% vs. 22%; p = .004) and biphasic reactions (10% vs. 4%; p = .001) were more commonly reported in peanut anaphylaxis. Most cases were labelled as severe anaphylaxis (Ring&Messmer grade III 65% vs. 56% and grade IV 1.1% vs. 0.9%; p = .001). Self-administration of intramuscular adrenaline was low (17% vs. 15%), professional adrenaline administration was higher in non-peanut food anaphylaxis (34% vs. 26%; p = .003). Hospitalization was higher for peanut anaphylaxis (67% vs. 54%; p = .004).

Conclusions

The European Anaphylaxis Registry data confirmed peanut as one of the major causes of severe, potentially life-threatening allergic reactions in European children, with some characteristic features e.g., presence of asthma comorbidity and increased rate of biphasic reactions. Usage of intramuscular adrenaline as first-line treatment is low and needs to be improved. The Registry, designed as the largest database on anaphylaxis, allows continuous assessment of this condition.
  相似文献   
5.
6.
7.
Quantitative risk assessment (QRA) for food allergens has made considerable progress in recent years, yet acceptability of its outcomes remains stymied because of the limited extent to which it has been possible to incorporate severity as a variable. Reaction severity, particularly following accidental exposure, depends on multiple factors, related to the allergen, the host and any treatments, which might be administered. Some of these factors are plausibly still unknown. Quantitative risk assessment shows that limiting exposure through control of dose reduces the rates of reactions in allergic populations, but its impact on the relative frequency of severe reactions at different doses is unclear. Food challenge studies suggest that the relationship between dose of allergenic food and reaction severity is complex even under relatively controlled conditions. Because of these complexities, epidemiological studies provide very limited insight into this aspect of the dose‐response relationship. Emerging data from single‐dose challenges suggest that graded food challenges may overestimate the rate of severe reactions. It may be necessary to generate new data (such as those from single‐dose challenges) to reliably identify the effect of dose on severity for use in QRA. Success will reduce uncertainty in the susceptible population and improve consumer choice.  相似文献   
8.
9.
Peanut allergy (PNA) is the main cause of food-induced anaphylaxis. Severe allergic reactions are more likely to occur in older patients and those with underlying asthma. Skin prick testing and measuring serum-specific IgE and recombinant peanut protein levels have been shown to be useful in the diagnosis of PNA and prediction of reactivity, but these tests are less consistent and reliable in terms of predicting the severity of reactions. Recent research has examined the role of biological mediators in allergic reactions such as platelet-activating factor. These may provide a future tool in predicting those at risk of severe reactions. Currently, there are no parameters that can predict with certainty those at risk of anaphylaxis, and management of PNA should continue to focus on patient and family education.  相似文献   
10.
David M. Fleischer  Scott Sicherer  Matthew Greenhawt  Dianne Campbell  Edmond Chan  Antonella Muraro  Susanne Halken  Yitzhak Katz  Motohiro Ebisawa  Lawrence Eichenfield  Hugh Sampson  Gideon Lack  George Du Toit  Graham Roberts  Henry Bahnson  Mary Feeney  Jonathan Hourihane  Jonathan Spergel  Michael Young  Amal As'aad  Katrina Allen  Susan Prescott  Sandeep Kapur  Hirohisa Saito  Ioana Agache  Cezmi A. Akdis  Hasan Arshad  Kirsten Beyer  Anthony Dubois  Philippe Eigenmann  Monserrat Fernandez‐Rivas  Kate Grimshaw  Karin Hoffman‐Sommergruber  Arne Host  Susanne Lau  Liam O'Mahony  Clare Mills  Nikolaus Papadopoulos  Carina Venter  Nancy Agmon‐Levin  Aaron Kessel  Richard Antaya  Beth Drolet  Lanny Rosenwasser 《Pediatric dermatology》2016,33(1):103-106
The purpose of this brief communication is to highlight emerging evidence regarding potential benefits of supporting early rather than delayed peanut introduction during the period of complementary food introduction in infants. This document should be considered as interim guidance based on consensus among the following organizations: American Academy of Allergy, Asthma, and Immunology, American Academy of Pediatrics, American College of Allergy, Asthma, and Immunology, Australasian Society of Clinical Immunology and Allergy, Canadian Society of Allergy and Clinical Immunology, European Academy of Allergy and Clinical Immunology, Israel Association of Allergy and Clinical Immunology, Japanese Society for Allergology, Society for Pediatric Dermatology, and World Allergy Organization. More formal guidelines regarding early‐life, complementary feeding practices and the risk of allergy development will follow in the next year from the National Institute of Allergy and Infectious Diseases—sponsored Working Group and the European Academy of Allergy and Clinical Immunology.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号